Table II.
Details of individual SCD patients with gout.
| Age at onset (years) |
Sex | SC/SS | Hydroxycarbamide | HTN | BMI | Fam Hx | Joints involved | Serum UA (µmol/l) |
UA crystals in joint |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 56 | M | SS | No | No | 36·1 | No | R ankle | 406·6–998·9 | IA |
| 2 | 24 | M | SS | Yes | Yes | 20·3 | No | L 1st MTP | 671·8–813·3 | Yes |
| 3 | 51 | F | SS | Yes | Yes | 31 | Yes | L ankle | 786·8–972·4 | ND |
| 4 | 47 | F | SS | Yes | Yes | 25·9 | No | R 3rd MTP | 831·0–919·4 | ND |
| 5 | 31 | F | SS | Yes | No | 25·1 | No | R ankle, R and L 1st MTP | 875·2–1034·3 | IA |
| 6 | 49 | M | SS | Yes | Yes | 23·4 | No | L 1st MTP | 583·4–663·0 | Refused |
| 7 | 27 | M | SS | No | Yes | 22·2 | No | R wrist, R 3rd PIP | 1131·5–1149·2 | Yes |
| 8 | 77 | F | SC | Yes | Yes | 30·2 | No | R 1st MTP, L 1st MTP | 477·4–742·6 | ND |
| 9 | 30 | M | SS | Yes | No | 20·2 | No | R wrist | 610·0–689·5 | IA |
| 10 | 23 | F | SS | Yes | No | 25·5 | No | R 1st MTP, R ankle | 397·8–477·4 | ND |
| 11 | 24 | M | SS | No | Yes | 23·2 | No | R elbow, R 3rd PIP and DIP, R 4th MCP | 530·4-663·0 | Yes |
| 12 | 40 | F | SS | Yes | Yes | 19·2 | No | R 1st MTP | 468·5–645·3 | ND |
| 13 | 40 | M | SS | Yes | No | 22·5 | No | R Knee | 857·5–1016·6 | IA |
M, male; F, female; DM, diabetes; HTN, hypertension; BMI, body mass index; Fam Hx, family history; R, right; L, left; MTP, metatarsophalangeal joint; MCP, metacarpophalangeal joint; PIP, proximal interphalangeal joint; DIP, distal interphalangeal joint; ND, not done; IA, insufficient amount of aspirate for crystal analysis; UA, uric acid.